Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
Ila R. Singh, John E. Gorzynski, Daria Drobysheva et al. · 2010
Read Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome by Ila R. Singh, John E. Gorzynski, Daria Drobysheva et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009948.txt.
Description
A virus found in some prostate tumors and chronic fatigue patients drew wide attention in 2009. Ila Singh and colleagues tested whether an HIV drug could stop it. Their study appeared in PLOS ONE in 2010. The virus's role in disease was debated at the time.
The virus is XMRV, a retrovirus implicated in both conditions named above. Raltegravir proved a potent inhibitor of the virus in lab tests. The drug was built to block HIV's integration into DNA. A ready-made drug with this power gave researchers a fast lead. It gave the XMRV debate one concrete test result.
Catalog record
| CREATOR | Ila R. Singh, John E. Gorzynski, Daria Drobysheva et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009948